Studies have shown that elevated serum HE4 correlates positively with advanced age, menopause, higher FIGO stage and grade, greater tumour size, deep myometrial invasion, lymph node involvement and reduced survival [17,20,21,22,23,24]. This evidence concerns the gene WFDC2 and neoplasm.